News
The State Council's Special Inspection Team on Promoting Private Investment Visits Wanbangde Pharmaceutical Group for an Inspection.
Date:
01 Mar,2021
To fully unlock and stimulate the potential for private investment and foster innovation, boost the confidence of private enterprises, and create an environment conducive to their growth and development, on May 28, the eighth special inspection team from the State Council tasked with promoting private investment arrived in Wenling City to conduct a research visit. That morning, the delegation—led by He Shixin, Deputy Director of the Development Planning Department at the National Defense Science, Industry, and Technology Bureau under China’s Ministry of Industry and Information Technology; Yan Guanyu, Deputy Director of the Rural Water Resources Division at China’s Ministry of Water Resources; Shi Fuhai, Director of the Science and Technology Audit Division at the National Audit Office; Wen Xiaolong, Deputy Researcher from the Investment Department of China’s National Development and Reform Commission; Liu Xiaoyong, Director of the Development Research Center at the Ministry of Water Resources; and Zhu Yuejun, a reporter from the People’s Daily—was accompanied by Liu Yuanli, Deputy Secretary-General of the Zhejiang Provincial Government; Qu Wenbin, Member of the Party Leadership Group at Taizhou Municipal Development and Reform Commission; Chen Gang, Vice Mayor of Wenling City; and Zhao Shouming, Chairman of Wanbangde Pharmaceutical Group. Together, they conducted an on-site inspection of Wanbangde Pharmaceutical Group.
The State Council Inspection Team toured the product exhibition hall, R&D center, and production workshops of Wanbangde Pharmaceutical Group. During their visit, team leaders attentively listened to Chairman Zhao Shouming’s detailed report on the company’s growth journey, product development, current investment status, and future strategic plans. They commended Wanbangde Pharmaceutical Group for its healthy, steady, and rapid progress, while also expressing high appreciation for the company’s state-of-the-art production lines and meticulous management practices. Additionally, the team acknowledged Wanbangde Pharmaceutical Group as an outstanding corporate representative that has made significant contributions to the nation’s economic development. Furthermore, the inspection team emphasized that Wanbangde Pharmaceutical Group has effectively leveraged its unique strengths, aligning them with favorable government policies and financial support, thereby demonstrating remarkable foresight and innovation as a private enterprise. This approach serves as a valuable model for other companies—particularly private enterprises and private capital—to emulate and learn from in their own pursuit of independent innovation.
Related Recommendations
2021/02/07